In eget turpis eget urna molestie ultricies in sagittis nunc. Sed accumsan leo in mauris rhoncus volutpat. Sed magna sapien, euismod convallis sagittis quis, varius sit amet mauris. Vivamus id quam congue venenatis et at lorem. Ut ullamcorper odio id metus eleifend tincidunt. Proin ante arcu, aliquam nec rhoncus sit amet, consequat vitae lorem. Ellentesque mollis laoreet laoreet. Nulla ut nulla sed mauris tempor pulvinar. Morbi quis nulla sit amet mi vestibulum vehicula. Pellentesque lectus metus, gravida ac sollicitudin at, ornare vel justo. Sed id arcu ac ligula malesuada accumsan.
Vivamus risus ipsum, vestibulum ut pellentesque iaculis, tempus vitae eros. Aliquam in orci non ipsum eleifend scelerisque ac id urna. Etiam tristique egestas mauris eu fringilla. Phasellus ac neque a orci mattis tincidunt eget eget ante. Maecenas placerat sapien quis purus scelerisque sed porta urna vehicula. Sed eros turpis, bibendum non ullamcorper at, euismod in nulla. Morbi eleifend sodales risus. Maecenas eu nisl ut ante dictum scelerisque. Quisque quis tempus metus. Donec sit amet diam leo, non fermentum leo. Quisque eget nulla tortor, sed vestibulum nisl.
Peptide Sciences Tirzepatide vs Semaglutide vs Retatrutide – A Research Comparison
The incretin peptide science tirzepatide family has expanded dramatically over the past
decade. Researchers now have access to multiple receptor-targeting strategies,
from selective GLP-1 agonism to dual and triple receptor activation. This
evolution mirrors the broader trend in precision medicine, where multi-targeted
approaches are increasingly investigated for complex metabolic conditions.
Semaglutide, tirzepatide, and retatrutide represent three distinct generations of research peptides
targeting metabolic pathways. Understanding their differences – receptor profiles,
half-lives, signaling biases, and research applications
– is essential for designing rigorous preclinical studies.
This comprehensive comparison guide examines all three peptides available from Peptide Sciences™ , helping researchers select the right tool for their specific
experimental questions.
For additional context, commercial information on GLP-1-based therapies can be
found at NovoWegovy , and other research suppliers like Paramount Peptides also offer similar compounds.
However, as emphasized in our guide on where to buy research
peptides , always verify quality standards regardless of supplier.
Three Peptides, Three Mechanisms
At a Glance Comparison Table
Feature Semaglutide Tirzepatide Retatrutide
Receptor targets GLP-1 only GLP-1 + GIP GLP-1 + GIP + glucagon
Number of agonists Single Dual (two) Triple (three)
Half-life (animal models) ~7 days ~5 days ~6 days
Molecular weight (Da) 4,113.6 4,813.4 ~4,900
Amino acid length 31 39 ~40
Peptide Sciences™ purity ≥99% ≥98.5% ≥98%
Primary research use Selective GLP-1 studies Dual pathway
mapping Triple-receptor signaling
Fatty acid modification C18 at Lys26 C20 at Lys20 C18/C20 hybrid
DPP-4 resistance Yes (Aib substitutions) Yes (Aib substitutions) Yes (Aib substitutions)
SKU PS-SEMA-5mg PS-TIRZ-10mg PS-RETA-10mg
The Incretin System: Background for Researchers
Before diving into each peptide, a brief overview
of the incretin system is helpful.
Incretins are gut-derived hormones that potentiate insulin secretion in response to meals.
The two primary incretins are:
Hormone Receptor Primary Effects Secreted By
GLP-1 (Glucagon-Like Peptide-1) GLP-1R Insulin secretion, satiety,
gastric emptying L-cells (ileum, colon)
GIP (Glucose-dependent Insulinotropic Polypeptide) GIP-R Insulin secretion, fat metabolism,